Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 233

1.

The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).

Brown JC, Caan BJ, Meyerhardt JA, Weltzien E, Xiao J, Cespedes Feliciano EM, Kroenke CH, Castillo A, Kwan ML, Prado CM.

J Cachexia Sarcopenia Muscle. 2018 May 15. doi: 10.1002/jcsm.12305. [Epub ahead of print]

2.

The Obesity Paradox in Cancer: How Important Is Muscle?

Cespedes Feliciano EM, Kroenke CH, Caan BJ.

Annu Rev Nutr. 2018 May 4. doi: 10.1146/annurev-nutr-082117-051723. [Epub ahead of print]

PMID:
29727593
3.

Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer.

Xiao J, Caan BJ, Weltzien E, Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Baracos VE, Kwan ML, Castillo AL, Prado CM.

J Cachexia Sarcopenia Muscle. 2018 Apr 19. doi: 10.1002/jcsm.12301. [Epub ahead of print]

4.

The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint.

Caan BJ, Cespedes Feliciano EM, Kroenke CH.

Cancer Res. 2018 Apr 15;78(8):1906-1912. doi: 10.1158/0008-5472.CAN-17-3287. Review.

PMID:
29654153
5.

The Plausibility of the Obesity Paradox in Cancer-Response-Reply to Point.

Cespedes Feliciano EM, Kroenke CH, Caan BJ.

Cancer Res. 2018 Apr 15;78(8):1904-1905. doi: 10.1158/0008-5472.CAN-17-3590. Review. No abstract available.

PMID:
29654152
6.

Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15.

Madsen MJ, Knight S, Sweeney C, Factor R, Salama M, Stijleman IJ, Rajamanickam V, Welm BE, Arunachalam S, Jones B, Rachamadugu R, Rowe K, Cessna MH, Thomas A, Kushi LH, Caan BJ, Bernard PS, Camp NJ.

Cancer Epidemiol Biomarkers Prev. 2018 Apr 12. doi: 10.1158/1055-9965.EPI-17-0887. [Epub ahead of print]

PMID:
29650789
7.

Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.

Caan BJ, Cespedes Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, Quesenberry CP, Weltzien EK, Castillo AL, Olobatuyi TA, Chen WY.

JAMA Oncol. 2018 Apr 5. doi: 10.1001/jamaoncol.2018.0137. [Epub ahead of print]

PMID:
29621380
8.

The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants.

Paskett ED, Caan BJ, Johnson L, Bernardo BM, Young GS, Pennell ML, Ray RM, Kroenke CH, Porter PL, Anderson GL.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):125-137. doi: 10.1158/1055-9965.EPI-17-0581. Epub 2018 Jan 29.

PMID:
29378785
9.

Explaining the Obesity Paradox-Response.

Caan BJ, Meyerhardt JA, Prado CM.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1576. doi: 10.1158/1055-9965.EPI-17-0613. No abstract available.

PMID:
28971997
10.

Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Dunne RF, Mustian KM, Garcia JM, Dale W, Hayward R, Roussel B, Buschmann MM, Caan BJ, Cole CL, Fleming FJ, Chakkalakal JV, Linehan DC, Hezel AF, Mohile SG.

Curr Opin Support Palliat Care. 2017 Dec;11(4):278-286. doi: 10.1097/SPC.0000000000000301.

PMID:
28957880
11.

Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival.

Sharafeldin N, Slattery ML, Liu Q, Franco-Villalobos C, Caan BJ, Potter JD, Yasui Y.

Int J Environ Res Public Health. 2017 Sep 28;14(10). pii: E1146. doi: 10.3390/ijerph14101146.

12.

Use of iDXA spine scans to evaluate total and visceral abdominal fat.

Bea JW, Hsu CH, Blew RM, Irving AP, Caan BJ, Kwan ML, Abraham I, Going SB.

Am J Hum Biol. 2018 Jan;30(1). doi: 10.1002/ajhb.23057. Epub 2017 Sep 8.

PMID:
28884861
13.

Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.

Cespedes Feliciano EM, Lee VS, Prado CM, Meyerhardt JA, Alexeeff S, Kroenke CH, Xiao J, Castillo AL, Caan BJ.

Cancer. 2017 Dec 15;123(24):4868-4877. doi: 10.1002/cncr.30950. Epub 2017 Sep 7.

PMID:
28881381
14.

Methodological considerations for disentangling a risk factor's influence on disease incidence versus postdiagnosis survival: The example of obesity and breast and colorectal cancer mortality in the Women's Health Initiative.

Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng TD, Chlebowski RT, Saquib N, Nassir R, Anderson G, Caan BJ.

Int J Cancer. 2017 Dec 1;141(11):2281-2290. doi: 10.1002/ijc.30931. Epub 2017 Aug 31.

PMID:
28833074
15.

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.

Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, Castillo AL, Caan BJ.

JAMA Oncol. 2017 Dec 1;3(12):e172319. doi: 10.1001/jamaoncol.2017.2319.

PMID:
28796857
16.

Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).

Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, Prado CM.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1008-1015. doi: 10.1158/1055-9965.EPI-17-0200. Epub 2017 May 15.

PMID:
28506965
17.

Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.

Cespedes Feliciano EM, Kwan ML, Kushi LH, Chen WY, Weltzien EK, Castillo AL, Sweeney C, Bernard PS, Caan BJ.

Cancer. 2017 Jul 1;123(13):2535-2542. doi: 10.1002/cncr.30637. Epub 2017 Mar 13.

PMID:
28295245
18.

Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors.

Cespedes Feliciano EM, Kwan ML, Kushi LH, Weltzien EK, Castillo AL, Caan BJ.

Breast Cancer Res Treat. 2017 Apr;162(3):549-557. doi: 10.1007/s10549-017-4133-8. Epub 2017 Feb 7.

19.

Next Steps in Understanding the Obesity Paradox in Cancer.

Caan BJ, Kroenke CH.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):12. doi: 10.1158/1055-9965.EPI-16-0764. No abstract available.

20.

Weight Fluctuation and Cancer Risk in Postmenopausal Women: The Women's Health Initiative.

Welti LM, Beavers DP, Caan BJ, Sangi-Haghpeykar H, Vitolins MZ, Beavers KM.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):779-786. doi: 10.1158/1055-9965.EPI-16-0611. Epub 2017 Jan 9.

Supplemental Content

Loading ...
Support Center